Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_assertion type Assertion NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_head.
- NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_assertion description "[We conclude that DEK-CAN molecular monitoring by RQ-PCR in t(6;9) malignancies is a useful tool for individual patient management and that molecular negativity is indispensable for survival, but should not be a prerequisite for allografting in this rare, poor prognosis, subset of AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_provenance.
- NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_assertion evidence source_evidence_literature NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_provenance.
- NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_assertion SIO_000772 15973457 NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_provenance.
- NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_assertion wasDerivedFrom befree-20150227 NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_provenance.
- NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_assertion wasGeneratedBy ECO_0000203 NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_provenance.